Verition Fund Management Acquires Stake in Semler Scientific, Inc.

Verition Fund Management LLC has made a strategic move by purchasing a new stake in Semler Scientific, Inc. (NASDAQ:SMLR). This acquisition took place during the third quarter, as revealed in the company’s latest filing with the Securities and Exchange Commission (SEC). The fund acquired 10,645 shares of Semler's stock, which is valued at approximately $251,000. Following this purchase, Verition Fund Management now holds approximately 0.15% of Semler Scientific.

In addition to Verition's acquisition, several other institutional investors and hedge funds have recently adjusted their positions in Semler Scientific. Notably, Cerity Partners LLC significantly increased its holdings in the company by 91.5% during the third quarter, obtaining a total of 1,345,586 shares worth about $31,689,000 after acquiring an additional 642,982 shares. Similarly, Shariaportfolio Inc. established a new position in Semler during the same quarter, valued at roughly $3,618,000.

Moreover, AQR Capital Management LLC boosted its stake in Semler Scientific by 150.1% in the second quarter, bringing its total to 140,498 shares valued at around $4,833,000 after adding 84,314 shares. In a separate development, Crawford Fund Management LLC also entered the market, purchasing a new stake in Semler during the third quarter for about $883,000. Finally, Dimensional Fund Advisors LP increased its stake in the company by 18.3% during the second quarter, now holding 126,177 shares worth approximately $4,341,000. Collectively, these institutional investors own about 49.37% of Semler Scientific's shares.

Stock Performance of Semler Scientific

On the day of reporting Friday, NASDAQ:SMLR opened at $67.17. Semler Scientific has a market capitalization of $556.77 million, a price-to-earnings (PE) ratio of 32.77, and a beta of 1.18. The stock has experienced a 50-day simple moving average of $43.82 and a 200-day simple moving average of $34.79, with a notable 52-week low of $20.88 and a high of $79.45.

Recently, Semler Scientific reported its quarterly earnings on November 4. For the quarter, the company delivered earnings per share (EPS) of $0.72, surpassing analysts' estimates of $0.37 by $0.35. The revenue recorded for this period was $13.51 million, with a net margin of 27.00% and a return on equity of 20.31%.

About Semler Scientific

Semler Scientific, Inc. is dedicated to providing technological solutions aimed at improving the clinical effectiveness and efficiency of healthcare providers across the United States. One of their flagship products, QuantaFlo, is a rapid four-minute office blood flow test that enables healthcare providers to incorporate blood flow measurements as part of their assessments of patients' vascular conditions.

investment, acquisition, stocks